Logo image of SGBX

SAFE & GREEN HOLDINGS CORP (SGBX) Stock Fundamental Analysis

NASDAQ:SGBX - US78418A6047 - Common Stock

7.48 USD
+0.03 (+0.4%)
Last: 9/9/2025, 8:09:17 PM
7.51 USD
+0.03 (+0.4%)
Pre-Market: 9/10/2025, 5:11:40 AM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SGBX. SGBX was compared to 52 industry peers in the Construction & Engineering industry. SGBX may be in some trouble as it scores bad on both profitability and health. SGBX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SGBX has reported negative net income.
SGBX had a negative operating cash flow in the past year.
SGBX had negative earnings in each of the past 5 years.
In the past 5 years SGBX always reported negative operating cash flow.
SGBX Yearly Net Income VS EBIT VS OCF VS FCFSGBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of SGBX (-41.17%) is worse than 86.54% of its industry peers.
The Return On Equity of SGBX (-93.21%) is worse than 82.69% of its industry peers.
Industry RankSector Rank
ROA -41.17%
ROE -93.21%
ROIC N/A
ROA(3y)-185.43%
ROA(5y)-120.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGBX Yearly ROA, ROE, ROICSGBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SGBX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGBX Yearly Profit, Operating, Gross MarginsSGBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

1

2. Health

2.1 Basic Checks

SGBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
SGBX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SGBX has more shares outstanding
Compared to 1 year ago, SGBX has a worse debt to assets ratio.
SGBX Yearly Shares OutstandingSGBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
SGBX Yearly Total Debt VS Total AssetsSGBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SGBX has an Altman-Z score of 0.81. This is a bad value and indicates that SGBX is not financially healthy and even has some risk of bankruptcy.
SGBX has a Altman-Z score of 0.81. This is in the lower half of the industry: SGBX underperforms 78.85% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that SGBX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.22, SGBX is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACCN/A
WACC10.53%
SGBX Yearly LT Debt VS Equity VS FCFSGBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

SGBX has a Current Ratio of 0.16. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SGBX (0.16) is worse than 88.46% of its industry peers.
SGBX has a Quick Ratio of 0.16. This is a bad value and indicates that SGBX is not financially healthy enough and could expect problems in meeting its short term obligations.
SGBX has a worse Quick ratio (0.13) than 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.13
SGBX Yearly Current Assets VS Current LiabilitesSGBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 80.61% over the past year.
The Revenue for SGBX has decreased by -55.21% in the past year. This is quite bad
The Revenue has been growing by 10.76% on average over the past years. This is quite good.
EPS 1Y (TTM)80.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.94%
Revenue 1Y (TTM)-55.21%
Revenue growth 3Y-49.37%
Revenue growth 5Y10.76%
Sales Q2Q%-66.9%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y27.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year39.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SGBX Yearly Revenue VS EstimatesSGBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
SGBX Yearly EPS VS EstimatesSGBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SGBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SGBX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGBX Price Earnings VS Forward Price EarningsSGBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGBX Per share dataSGBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SGBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFE & GREEN HOLDINGS CORP

NASDAQ:SGBX (9/9/2025, 8:09:17 PM)

Premarket: 7.51 +0.03 (+0.4%)

7.48

+0.03 (+0.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-24 2025-11-24
Inst Owners5.06%
Inst Owner Change428.02%
Ins Owners16.55%
Ins Owner Change0%
Market Cap231.28M
Analysts82.86
Price TargetN/A
Short Float %10.2%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 56.62
P/FCF N/A
P/OCF N/A
P/B 9.74
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.37
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.13
BVpS0.77
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.17%
ROE -93.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.43%
ROA(5y)-120.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.48%
Cap/Sales 6.49%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.13
Altman-Z 0.81
F-Score3
WACC10.53%
ROIC/WACCN/A
Cap/Depr(3y)218.94%
Cap/Depr(5y)483.55%
Cap/Sales(3y)6.13%
Cap/Sales(5y)10.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.94%
EPS Next Y27.82%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-55.21%
Revenue growth 3Y-49.37%
Revenue growth 5Y10.76%
Sales Q2Q%-66.9%
Revenue Next Year39.31%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-93.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-185.99%
OCF growth 3YN/A
OCF growth 5YN/A